VanEck Associates’s Carter's CRI Stock Holding History

VanEck Associates’s Portfolio CRI Stock Details CRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,080	Closed	-$99K	–	1387
2022 Q1	$99K	Buy	1,080 +148	+16%	+$13.9K	﹤0.01%	1234
2021 Q4	$94K	Buy	+932	New	+$95K	﹤0.01%	1256

Other funds holding CRI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VanEck Associates's CRI Position: Q2 2022 in Review

VanEck Associates sold out of Carter's (CRI) in Q2 2022, closing a stake of 1,080 shares — an estimated $99K sold.

VanEck Associates first reported a position in CRI in Q4 2021 and held it in 2 quarters. The position peaked at $99K in Q1 2022. 315 funds tracked by Wall St. Rank hold CRI as of Q2 2022.

VanEck Associates reported no remaining Carter's position as of Q2 2022 after selling out during the quarter.
VanEck Associates sold 1,080 Carter's shares in Q2 2022, an estimated $99K.
VanEck Associates first reported a position in Carter's in Q4 2021 and held it in 2 quarters.
VanEck Associates's Carter's position peaked at $99K in Q1 2022.
315 funds tracked by Wall St. Rank held Carter's as of Q2 2022.

Based on VanEck Associates's 13F filing for Q2 2022, filed 3 Aug 2022.